We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+3.84%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$16.5B
AUM Growth
-$1.93B
(-10%)
Cap. Flow
-$2.26B
Cap. Flow
% of AUM
-13.67%
Top 10 Holdings %
Top 10 Hldgs %
16.19%
Holding
1,547
New
416
Increased
366
Reduced
319
Closed
426
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$233M |
| 2 |
TSMC
TSM
|
+$222M |
| 3 |
Philip Morris
PM
|
+$189M |
| 4 |
Qualcomm
QCOM
|
+$171M |
| 5 |
AstraZeneca
AZN
|
+$127M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vodafone
VOD
|
+$396M |
| 2 |
Citigroup
C
|
+$269M |
| 3 |
Cisco
CSCO
|
+$253M |
| 4 |
Boeing
BA
|
+$166M |
| 5 |
Bank of America
BAC
|
+$164M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.96% |
| 2 | Technology | 21.61% |
| 3 | Consumer Staples | 8.79% |
| 4 | Communication Services | 8.54% |
| 5 | Financials | 8.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Huntington Ingalls Industries
HII
$12.8B
| $2.55M | 0.02% |
24,904
-156,919
| -86% | -$15.2M |
|
602
Provident Financial Services
PFS
$3.19B
| $2.52M | 0.02% |
137,120
+9,597
| +8% | +$174K |
|
603
Ultrapar
UGP
$6.54B
| $2.51M | 0.02% |
208,742
-482,874
| -70% | -$5.38M |
|
|
STR
604
DELISTED
QUESTAR CORP
STR
| $2.51M | 0.02% |
+105,515
| New | +$2.46M |
|
|
NM
605
DELISTED
Navios Maritime Holdings Inc.
NM
| $2.5M | 0.02% |
25,435
-23,617
| -48% | -$2.31M |
|
606
Weis Markets
WMK
$1.86B
| $2.49M | 0.02% |
50,516
+12,104
| +32% | +$601K |
|
|
TRIB
607
Trinity Biotech
TRIB
$8.39M
| $2.48M | 0.02% |
682
-241
| -26% | -$948K |
|
608
Sonoco
SON
$5.74B
| $2.47M | 0.02% |
+60,322
| New | +$2.51M |
|
|
CBF
609
DELISTED
Capital Bank Financial Corp. Class A Common Stock
CBF
| $2.46M | 0.01% |
97,830
+11,050
| +13% | +$260K |
|
|
MNTA
610
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $2.46M | 0.01% |
210,743
+106,714
| +103% | +$1.81M |
|
|
TRNX
611
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $2.45M | 0.01% |
+115,490
| New | +$2.24M |
|
612
Magnachip Semiconductor
MX
$145M
| $2.45M | 0.01% |
175,657
+59,209
| +51% | +$946K |
|
613
Cognizant
CTSH
$26B
| $2.44M | 0.01% |
48,274
-121,032
| -71% | -$6.05M |
|
614
Ingles Markets
IMKTA
$1.67B
| $2.43M | 0.01% |
101,912
+16,754
| +20% | +$413K |
|
|
VRE
615
DELISTED
Veris Residential
VRE
| $2.41M | 0.01% |
+115,784
| New | +$2.44M |
|
616
Sysco
SYY
$40.3B
| $2.4M | 0.01% |
+66,333
| New | +$2.38M |
|
617
Enanta Pharmaceuticals
ENTA
$400M
| $2.39M | 0.01% |
+59,707
| New | +$2.17M |
|
|
AXIA.PR
618
DELISTED
AXIA Energia American Depositary Shares Preferred Class B1
AXIA.PR
| $2.38M | 0.01% |
640,453
+136,893
| +27% | +$437K |
|
|
XXIA
619
DELISTED
Ixia
XXIA
| $2.38M | 0.01% |
190,298
-51,456
| -21% | -$659K |
|
620
Petrobras Class A
PBR.A
$103B
| $2.37M | 0.01% |
170,547
-1,436,471
| -89% | -$17.7M |
|
621
Entegris
ENTG
$23.2B
| $2.33M | 0.01% |
+192,511
| New | +$2.24M |
|
|
AJRD
622
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $2.33M | 0.01% |
127,467
+18,903
| +17% | +$345K |
|
|
AVX
623
DELISTED
AVX Corporation
AVX
| $2.32M | 0.01% |
176,242
+88,263
| +100% | +$1.15M |
|
624
Align Technology
ALGN
$12.3B
| $2.31M | 0.01% |
+44,653
| New | +$2.5M |
|
|
CSC
625
DELISTED
Computer Sciences
CSC
| $2.29M | 0.01% |
89,417
-579,603
| -87% | -$14.6M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2014 Portfolio in Review
As of Q1 2014, Arrowstreet Capital held 1,547 positions worth $16.5B, down 10% from $18.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Arrowstreet Capital withdrew a net $2.26B in Q1 2014, closing 426 positions and reducing 319 holdings. Its most notable exit was GE Aerospace, an estimated $151M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Arrowstreet Capital opened a new position in Philip Morris worth $192M.
- Arrowstreet Capital's largest Q1 2014 buy was Philip Morris: 2,344,576 shares worth $192M.
- Arrowstreet Capital added most to GSK in Q1 2014, an estimated $233M increase.
- Arrowstreet Capital's biggest Q1 2014 reduction was Vodafone, cutting an estimated $396M.
- Arrowstreet Capital fully exited GE Aerospace in Q1 2014, selling an estimated $151M.
- Arrowstreet Capital's ten largest holdings make up 16% of its $16.5B portfolio in Q1 2014.
- Arrowstreet Capital opened 416 new positions and closed 426 in Q1 2014.
- Arrowstreet Capital's portfolio value fell 10% quarter-over-quarter to $16.5B.
Based on Arrowstreet Capital's 13F filing for Q1 2014, filed 15 May 2014.